ONCY
Price:
$0.96
Market Cap:
$136.49M
Oncolytics Biotech Inc. is a biopharmaceutical firm in its development phase, concentrating its efforts on discovering and creating novel pharmaceutical agents to combat cancer. Its primary therapeutic candidate is pelareorep, an immunotherapeutic drug delivered intravenously, designed to target and treat both solid tumors and various blood-related cancers. The company has established strategic co-development agreements with major pharmaceutical companies, Merck KGaA and Pfizer Inc., as well as with PrECOG LLC. These collaborations are focused on advancing pelareorep for use in conjunction with paclitaxel and avelumab (a human anti-PD-L1 antibody). This specific combination therapy is being ...[Read more]
Industry
Biotechnology
IPO Date
2001-10-05
Stock Exchange
NASDAQ
Ticker
ONCY
According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.00. This represents a change of -53.39% compared to the average of -6.44 of the last 4 quarters.
The mean historical PE Ratio of Oncolytics Biotech Inc. over the last ten years is -4.00. The current -3.00 PE Ratio has changed 7.40% with respect to the historical average. Over the past ten years (40 quarters), ONCY's PE Ratio was at its highest in in the March 2020 quarter at 43.70. The PE Ratio was at its lowest in in the December 2025 quarter at -15.70.
Average
-4.00
Median
-3.85
Minimum
-6.32
Maximum
-2.24
Discovering the peaks and valleys of Oncolytics Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 166.88%
Maximum Annual PE Ratio = -2.24
Minimum Annual Increase = -61.01%
Minimum Annual PE Ratio = -6.32
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.92 | -8.74% |
| 2024 | -3.21 | -24.80% |
| 2023 | -4.26 | -15.03% |
| 2022 | -5.02 | 39.90% |
| 2021 | -3.59 | -43.31% |
| 2020 | -6.32 | 53.61% |
| 2019 | -4.12 | 76.71% |
| 2018 | -2.33 | -61.01% |
| 2017 | -5.98 | 166.88% |
| 2016 | -2.24 | -26.91% |
The current PE Ratio of Oncolytics Biotech Inc. (ONCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.46
5-year avg
-3.80
10-year avg
-4.00
Oncolytics Biotech Inc.’s PE Ratio is less than Atossa Therapeutics, Inc. (-0.46), greater than Immix Biopharma, Inc. (-9.48), less than Whitehawk Therapeutics Inc (-2.63), less than Instil Bio, Inc. (-1.06), less than Zentalis Pharmaceuticals, Inc. (-2.14), greater than MacroGenics, Inc. (-3.75), less than Tevogen Bio Holdings Inc. (-1.62), greater than Coya Therapeutics, Inc. (-4.28), less than Clene Inc. (-1.85), less than Surrozen, Inc. (-0.56),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.46 | $17.31M | |
| -9.48 | $474.38M | |
| -2.63 | $218.58M | |
| -1.06 | $50.86M | |
| -2.14 | $263.39M | |
| -3.75 | $262.52M | |
| -1.62 | $39.91M | |
| -4.28 | $89.59M | |
| -1.85 | $61.95M | |
| -0.56 | $173.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Oncolytics Biotech Inc.'s PE Ratio?
How is the PE Ratio calculated for Oncolytics Biotech Inc. (ONCY)?
What is the highest PE Ratio for Oncolytics Biotech Inc. (ONCY)?
What is the 3-year average PE Ratio for Oncolytics Biotech Inc. (ONCY)?
What is the 5-year average PE Ratio for Oncolytics Biotech Inc. (ONCY)?
How does the current PE Ratio for Oncolytics Biotech Inc. (ONCY) compare to its historical average?